|
See related NovoNorm tab[諾和隆 錠] information |
|
|
|
製造商 |
Novo Nordisk |
|
代理/經銷商 |
Novo Nordisk |
|
成份 |
Repaglinide |
|
適應症 |
Type 2 diabetes (NIDDM) whose hyperglycaemia is not controlled satisfactorily by diet, weight reduction & exercise. NovoNorm can be used in combination with metformin. |
|
用量 |
Initially 0.5 mg, max single dose: 4 mg. Max: 16 mg/day. |
|
過量 |
View NovoNorm[諾和隆] overdosage for action to be taken in the event of an overdose. |
|
用法 |
Should be taken with food (Take within 15 mins of meals.). |
|
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
禁忌 |
Type 1 diabetes. Diabetic ketoacidosis with or without coma. Pregnancy, lactation. Children <12 years. Severe renal or hepatic dysfunction. Concomitant therapy with medicinal products which are CYP3A4 inhibitors or inducers. |
|
注意事項 |
Patients >75 years. |
|
不良反應 |
Hypoglycaemia, transient visual disturbances, GI disturbances. Hypersensitivity reactions of the skin.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
交互作用 |
MAOIs, non-selective β-blockers, ACE inhibitors, NSAIDs, salicylates, octreotide, alcohol & anabolic steroids. OCs, thiazides, corticosteroids, danazol, thyroid hormones & sympathomimetics, sulfonylureas, gemfibrozil.
View more drug interactions with NovoNorm[諾和隆] |
|
儲存 |
View NovoNorm[諾和隆] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View NovoNorm[諾和隆] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View NovoNorm[諾和隆] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
NovoNorm 錠劑 |
|
NovoNorm 1 mg x 90's |
 |
|
NovoNorm 1 mg x 120's |
|
|
|
|
Manufacturer: |
Novo Nordisk |
|
Distributor: |
Novo Nordisk |
|
|
|
